EPFL spin-off Aleva Neurotherapeutics has just raised 13 million dollars in its fourth fund-raising round. The company, based at EPFL’s Innovation Park, will use the proceeds to obtain EU market certification for its new deep brain stimulation (DBS) system.
Media properties
- Themes
- Research and Tech Transfer , Microengineering, Startups and Industry, Research and Tech Transfer, Neuroscience
- Copyright
- EPFL - Alain Herzog
- Licence
- CC0 Licence
- Shooting date
- Feb. 6, 2012
- Album
- Aleva Neurotherapeutics
Share on
